2026 - Phesi leads the way in 2026 Frost Radar™ benchmarking report for AI-enabled clinical trials

Phesi has emerged as the 2026 Global Growth Leader in Artificial-Intelligence Enabled Clinical Trials in a new benchmarking report from Frost & Sullivan. The Frost Radar™ for AI-Enabled Clinical Trials ranks the industry’s leading AI-enabled clinical development platform providers based on growth and innovation, recognizing Phesi as a transformative leader.

“Phesi has emerged as a transformative leader across the AI enabled Clinical Trials landscape. Phesi’s AI-driven clinical development solutions focus on patient and disease profiling, program and protocol design, investigator site and country selection, as part of a fully integrated feasibility offering. With the unique digital patient profile at its core the company operates on a truly patient centric model across 195 countries and 4,000+ indications from oncology to rare diseases. Phesi's AI-powered data science approach to strategic and operational feasibility, enables precise and efficient analysis of clinical trial data, significantly reducing time and costs.” Aarti Chitale, Industry Principal, Frost & Sullivan

2025 - Phesi is the winner of the Innovation award for AI-Enabled Trial Simulation

Phesi has been honored with the Innovation award in the 2025 Clinical Trials Arena Excellence Awards. One of the industry’s most prestigious and widely recognized programs, the Clinical Trials Arena Excellence Awards celebrate the greatest achievements and innovations in the industry. The program provides a platform to recognize the people and companies that are driving change across the world.

 2024 - Frost & Sullivan Best Practices Award

Phesi win Frost & Sullivan’s Global Enabling Technology Leadership Award for revolutionizing clinical development with its Trial Accelerator™ platform

 Frost & Sullivan applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final award recipient. The process involves a detailed evaluation of best practices criteria across two dimensions for each nominated company. Phesi excels in many of the criteria in the AI-enabled clinical trial design space.